$EXPI
eXp World Holdings Inc

2023 Q4 Form 10-K Financial Statement

#000155837024001527 Filed on February 22, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $983.0M $4.281B
YoY Change 5.32% -6.9%
Cost Of Revenue $912.2M $3.957B
YoY Change 7.28% -6.48%
Gross Profit $70.85M $324.1M
YoY Change -14.7% -11.68%
Gross Profit Margin 7.21% 7.57%
Selling, General & Admin $89.40M $331.3M
YoY Change -4.66% -8.35%
% of Gross Profit 126.17% 102.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.792M $10.89M
YoY Change 4.02% 10.71%
% of Gross Profit 3.94% 3.36%
Operating Expenses $89.40M $4.298B
YoY Change -4.66% -6.43%
Operating Profit -$18.55M -$16.46M
YoY Change 73.17% -404.38%
Interest Expense -$549.0K -$1.388M
YoY Change 33.58% -14.53%
% of Operating Profit
Other Income/Expense, Net $1.527M $3.026M
YoY Change 27.46% -469.02%
Pretax Income -$26.77M -$13.44M
YoY Change 169.8% -392.83%
Income Tax -$5.573M -$4.462M
% Of Pretax Income
Net Earnings -$21.20M -$8.973M
YoY Change 194.36% -158.11%
Net Earnings / Revenue -2.16% -0.21%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.14 -$0.06
COMMON SHARES
Basic Shares Outstanding 154.7M 153.2M
Diluted Shares Outstanding 153.2M

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $126.9M $126.9M
YoY Change 4.33% 4.33%
Cash & Equivalents $126.9M $126.9M
Short-Term Investments
Other Short-Term Assets $1.425M $53.64M
YoY Change 145.69% 15.97%
Inventory
Prepaid Expenses $5.726M
Receivables $85.97M $85.97M
Other Receivables $0.00 $0.00
Total Short-Term Assets $266.5M $266.5M
YoY Change 4.45% 4.45%
LONG-TERM ASSETS
Property, Plant & Equipment $12.98M $12.99M
YoY Change -28.5% -35.95%
Goodwill $16.98M
YoY Change -37.59%
Intangibles $10.48M
YoY Change 20.47%
Long-Term Investments
YoY Change
Other Assets $78.74M $78.74M
YoY Change 11.88% 11.88%
Total Long-Term Assets $119.2M $119.2M
YoY Change -5.83% -5.83%
TOTAL ASSETS
Total Short-Term Assets $266.5M $266.5M
Total Long-Term Assets $119.2M $119.2M
Total Assets $385.7M $385.7M
YoY Change 1.04% 1.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.898M $8.898M
YoY Change -14.37% -14.37%
Accrued Expenses $88.18M $86.97M
YoY Change 11.7% 12.95%
Deferred Revenue $44.55M
YoY Change 17.89%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $141.6M $141.6M
YoY Change 11.27% 11.27%
LONG-TERM LIABILITIES
Long-Term Debt $20.00K $20.00K
YoY Change -99.57% -99.57%
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $20.00K $20.00K
YoY Change -99.57% -99.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $141.6M $141.6M
Total Long-Term Liabilities $20.00K $20.00K
Total Liabilities $141.7M $142.8M
YoY Change 6.76% 6.7%
SHAREHOLDERS EQUITY
Retained Earnings -$16.77M
YoY Change -180.92%
Common Stock $804.8M
YoY Change 31.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $242.8M $242.8M
YoY Change
Total Liabilities & Shareholders Equity $385.7M $385.7M
YoY Change 1.04% 1.04%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$21.20M -$8.973M
YoY Change 194.36% -158.11%
Depreciation, Depletion And Amortization $2.792M $10.89M
YoY Change 4.02% 10.71%
Cash From Operating Activities $32.63M $209.1M
YoY Change 40.58% -0.67%
INVESTING ACTIVITIES
Capital Expenditures $1.857M $5.363M
YoY Change -34.36% -55.5%
Acquisitions
YoY Change
Other Investing Activities -$346.0K -$5.546M
YoY Change -53.37% -46.72%
Cash From Investing Activities -$2.203M -$13.50M
YoY Change -38.31% -39.88%
FINANCING ACTIVITIES
Cash Dividend Paid $28.52M
YoY Change 13.04%
Common Stock Issuance & Retirement, Net $160.6M
YoY Change -10.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -33.29M -184.1M
YoY Change -30.85% -9.99%
NET CHANGE
Cash From Operating Activities 32.63M 209.1M
Cash From Investing Activities -2.203M -13.50M
Cash From Financing Activities -33.29M -184.1M
Net Change In Cash -2.861M 11.50M
YoY Change -89.96% -169.59%
FREE CASH FLOW
Cash From Operating Activities $32.63M $209.1M
Capital Expenditures $1.857M $5.363M
Free Cash Flow $30.77M $203.8M
YoY Change 50.99% 2.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GoodwillAndIntangibleAssetImpairment
CY2022 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GoodwillAndIntangibleAssetImpairment
CY2023 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GoodwillAndIntangibleAssetImpairment
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001495932
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-38493
CY2023 dei Entity Registrant Name
EntityRegistrantName
eXp World Holdings, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0681092
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
2219 Rimland Drive, Suite 301
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Bellingham
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98226
CY2023 dei City Area Code
CityAreaCode
360
CY2023 dei Local Phone Number
LocalPhoneNumber
685-4206
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
CY2023 dei Trading Symbol
TradingSymbol
EXPI
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1300000000
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
154669037
CY2023 dei Auditor Firm
AuditorFirmId
34
CY2023 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2023 dei Auditor Location
AuditorLocation
San Francisco, California
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126864000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121594000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
44020000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
37789000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2303000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4014000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
85969000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
87262000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9622000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8468000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
266475000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
255113000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12978000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18151000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2127000
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
7400000
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1703000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10481000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8700000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
71342000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
68676000
CY2023Q4 us-gaap Goodwill
Goodwill
16982000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000
CY2023Q4 us-gaap Assets
Assets
385668000
CY2022Q4 us-gaap Assets
Assets
381682000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8898000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10391000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44550000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
37789000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88182000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78944000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
175000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
141640000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
127299000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4697000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
694000
CY2023Q4 us-gaap Liabilities
Liabilities
141660000
CY2022Q4 us-gaap Liabilities
Liabilities
132690000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
183606708
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154669037
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171656030
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152839239
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
804833000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
611872000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28937671
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
18816791
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
545559000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
385010000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16769000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20723000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
332000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
236000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
242839000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
247823000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
1169000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1169000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244008000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248992000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385668000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
381682000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4281105000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4598161000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3771170000
CY2023 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
3957054000
CY2022 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
4231262000
CY2021 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
3475139000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
319153000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
346132000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
249699000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12156000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15359000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12180000
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9203000
CY2023 us-gaap Operating Expenses
OperatingExpenses
4297566000
CY2022 us-gaap Operating Expenses
OperatingExpenses
4592753000
CY2021 us-gaap Operating Expenses
OperatingExpenses
3737018000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-16461000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
5408000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
34152000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4414000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
804000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-292000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1388000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1624000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-188000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3026000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-820000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-480000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13435000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4588000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33672000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4462000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10836000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-47487000
CY2023 us-gaap Profit Loss
ProfitLoss
-8973000
CY2022 us-gaap Profit Loss
ProfitLoss
15424000
CY2021 us-gaap Profit Loss
ProfitLoss
81159000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-61000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8973000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15442000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
81220000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153232129
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151036110
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146170871
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153232129
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156220165
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157729374
CY2023 us-gaap Profit Loss
ProfitLoss
-8973000
CY2022 us-gaap Profit Loss
ProfitLoss
15424000
CY2021 us-gaap Profit Loss
ProfitLoss
81159000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-61000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8973000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15442000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
81220000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
96000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
48000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-59000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8877000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15490000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
81161000
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.045
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.045
CY2021Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.04
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244008000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248992000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
223533000
CY2023 us-gaap Profit Loss
ProfitLoss
-8973000
CY2022 us-gaap Profit Loss
ProfitLoss
15424000
CY2021 us-gaap Profit Loss
ProfitLoss
81159000
CY2023 us-gaap Depreciation
Depreciation
8352000
CY2022 us-gaap Depreciation
Depreciation
7934000
CY2021 us-gaap Depreciation
Depreciation
4974000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2540000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1904000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1274000
CY2021 expi Amortization Expense Related To Discount Applied In Business Combination
AmortizationExpenseRelatedToDiscountAppliedInBusinessCombination
94000
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9203000
CY2023 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
472000
CY2022 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
361000
CY2023 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-1711000
CY2022 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1816000
CY2021 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
319000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1388000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1624000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-188000
CY2023 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
43178000
CY2022 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
30861000
CY2021 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
24493000
CY2023 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
10736000
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14442000
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
13102000
CY2023 expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
135226000
CY2022 expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
164104000
CY2021 expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
144437000
CY2023 expi Deferred Tax Asset Change
DeferredTaxAssetChange
-2666000
CY2022 expi Deferred Tax Asset Change
DeferredTaxAssetChange
-15848000
CY2021 expi Deferred Tax Asset Change
DeferredTaxAssetChange
-52827000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3474000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-44935000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
56857000
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1263000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1652000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2623000
CY2023 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-6761000
CY2022 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
30998000
CY2021 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-39892000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1491000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2432000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3173000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8424000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-32239000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
46673000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4677000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1983000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
828000
CY2023 expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
158000
CY2022 expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
148000
CY2021 expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
-1407000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
209131000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
210535000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
246892000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5363000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12051000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13423000
CY2023 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
330000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9910000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2500000
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5876000
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
500000
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3000000
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2594000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13503000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22461000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18923000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
160550000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
179473000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
172015000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4980000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
612000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3620000
CY2022 expi Payments To Proceeds From Noncontrolling Interests
PaymentsToProceedsFromNoncontrollingInterests
424000
CY2021 expi Payments To Proceeds From Noncontrolling Interests
PaymentsToProceedsFromNoncontrollingInterests
-19000
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
28519000
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
25229000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
11548000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-184089000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-204514000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-179924000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-38000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-87000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-59000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11501000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16527000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47986000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159383000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170884000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159383000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2731000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3406000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1331000
CY2023 expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
859000
CY2021 expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
375000
CY2022 us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
4554000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2370000
CY2023 expi Noncash Or Part Noncash Contingent Consideration For Disposition Of Business
NoncashOrPartNoncashContingentConsiderationForDispositionOfBusiness
1209000
CY2023 expi Property Plant And Equipment Increase Due To Transfer Of Lease Asset
PropertyPlantAndEquipmentIncreaseDueToTransferOfLeaseAsset
1100000
CY2023 expi Fixed Asset Purchases In Accounts Payable
FixedAssetPurchasesInAccountsPayable
63000
CY2022 expi Fixed Asset Purchases In Accounts Payable
FixedAssetPurchasesInAccountsPayable
63000
CY2021 expi Fixed Asset Purchases In Accounts Payable
FixedAssetPurchasesInAccountsPayable
174000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9622000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Roboto';font-size:9.5pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Use of estimates</span></p><p style="font-family:'Roboto';font-size:9.5pt;text-align:justify;margin:0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for credit losses, legal contingencies, income taxes, revenue recognition, stock-based compensation, goodwill and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company </span></p><p style="font-family:'Roboto';font-size:9.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p>
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Roboto';font-size:9.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Roboto';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">When necessary, the Company will reclassify certain amounts in prior period financial statements to conform to the current period’s presentation. In 2023, the Company reclassified certain amounts in the reconciliation of the provision for income taxes and deferred tax assets in </span><i style="font-family:'Arial','Helvetica','sans-serif';font-style:italic;">Note 12 – Income Taxes</i><span style="font-family:'Arial','Helvetica','sans-serif';">. These reclassifications had no effect on the provision for tax or deferred tax assets that were previously reported. No other reclassifications occurred during the current period. </span><span style="display:inline-block;width:29.54pt;"></span><span style="display:inline-block;width:36pt;"></span><span style="display:inline-block;width:36pt;"></span><span style="display:inline-block;width:36pt;"></span><span style="display:inline-block;width:36pt;"></span></p><p style="font-family:'Roboto';font-size:9.5pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Cash and cash equivalents</span></p><p style="font-family:'Roboto';font-size:9.5pt;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Cash and cash equivalents include cash on hand, money market instruments and all other highly liquid investments purchased with an original or remaining maturity of three months or less at the date of acquisition.</span></p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126864000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121594000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
44020000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
37789000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170884000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159383000
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
12156000
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
15359000
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
12180000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5726000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5580000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2471000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2293000
CY2022Q4 expi Deposits Assets Liabilities Current
DepositsAssetsLiabilitiesCurrent
15000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1425000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
580000
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
111000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8468000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39698000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34226000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27733000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19282000
CY2023Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
11965000
CY2022Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
14944000
CY2023Q4 expi Assets Under Development
AssetsUnderDevelopment
1013000
CY2022Q4 expi Assets Under Development
AssetsUnderDevelopment
3207000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12978000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18151000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8352000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7934000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4974000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000
CY2021Q4 us-gaap Goodwill
Goodwill
12945000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
14156000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
8248000
CY2023 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-2310000
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
328000
CY2023Q4 us-gaap Goodwill
Goodwill
16982000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
17836000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6400000
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
955000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10481000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12856000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4156000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8700000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2540000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1904000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1274000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2702000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2299000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1275000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
608000
CY2023Q4 expi Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
3597000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10481000
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
60010000
CY2022Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
56786000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8866000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6236000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1225000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2124000
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6751692
CY2023Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
4999000
CY2022Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
3885000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13082000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9913000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88182000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78944000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171656030
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155516284
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146677786
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
832993
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2105237
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3155170
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
183606708
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171656030
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155516284
CY2021Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
4341000
CY2022 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
2056000
CY2022 expi Stock Grants Reclassified From Liability To Equity
StockGrantsReclassifiedFromLiabilityToEquity
2512000
CY2022Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
3885000
CY2023 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
3832000
CY2023 expi Stock Grants Reclassified From Liability To Equity
StockGrantsReclassifiedFromLiabilityToEquity
2717000
CY2023Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
5000000
CY2018Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0
CY2022Q1 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
10000000.0
CY2022Q1 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
10000000.0
CY2022Q2 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
20000000.0
CY2022Q2 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
20000000.0
CY2022Q3 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
13300000
CY2022Q3 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
13300000
CY2022Q4 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
10000000.0
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0
CY2023Q4 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
12000000.0
CY2023Q4 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
8000000.0
CY2023Q4 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
12000000.0
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
18816791
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6751692
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2534494
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
10110152
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
12408430
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4217198
CY2023 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
10728
CY2022 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
343331
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28937671
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
18816791
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4281105000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4598161000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3771170000
CY2023 expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
57548000
CY2022 expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
60549000
CY2021 expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
77995000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10892000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9838000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6248000
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9203000
CY2023 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
43178000
CY2022 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
30861000
CY2021 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
24493000
CY2023 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
10736000
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14442000
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
13102000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-16461000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
5408000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
34152000
CY2023Q4 us-gaap Goodwill
Goodwill
16982000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000
CY2023Q4 us-gaap Goodwill
Goodwill
16982000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8973000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15442000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
81220000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153232129
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151036110
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146170871
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5184055
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11558503
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153232129
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156220165
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157729374
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4361775
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000421
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
102880
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-16522000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1029000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
32804000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
3087000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
3559000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
929000
CY2023 expi Income Loss From Continuing Operations Before Income Taxes Excluding Noncontrolling Interest Which Is Permanent Difference
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExcludingNoncontrollingInterestWhichIsPermanentDifference
-13435000
CY2022 expi Income Loss From Continuing Operations Before Income Taxes Excluding Noncontrolling Interest Which Is Permanent Difference
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExcludingNoncontrollingInterestWhichIsPermanentDifference
4588000
CY2021 expi Income Loss From Continuing Operations Before Income Taxes Excluding Noncontrolling Interest Which Is Permanent Difference
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExcludingNoncontrollingInterestWhichIsPermanentDifference
33733000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
305000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
795000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
737000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
456000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1788000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2312000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1650000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2888000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3049000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2106000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4995000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-11444000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-41599000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1494000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1674000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-6574000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-861000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-767000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1420000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7350000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13885000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-49593000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4462000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10836000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-47487000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0060
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.1752
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0522
CY2023 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
-0.0103
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.0040
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.0008
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.1548
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.4964
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0604
CY2023 expi Effective Income Tax Rate Reconciliation Unrecognized Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitPercent
-0.0387
CY2022 expi Effective Income Tax Rate Reconciliation Unrecognized Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitPercent
0.1241
CY2021 expi Effective Income Tax Rate Reconciliation Unrecognized Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitPercent
0.0151
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.2464
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-2.6542
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-1.0720
CY2023 expi Effective Income Tax Rate Reconciliation Related To Limitations Percent
EffectiveIncomeTaxRateReconciliationRelatedToLimitationsPercent
-0.2123
CY2022 expi Effective Income Tax Rate Reconciliation Related To Limitations Percent
EffectiveIncomeTaxRateReconciliationRelatedToLimitationsPercent
0.4785
CY2021 expi Effective Income Tax Rate Reconciliation Related To Limitations Percent
EffectiveIncomeTaxRateReconciliationRelatedToLimitationsPercent
0.0812
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0102
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0165
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0027
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.6554
CY2023 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.0329
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.1999
CY2021 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.0063
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0013
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0213
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0265
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3321
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-2.3619
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.4072
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
34028000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
41192000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
3127000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
3129000
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1782000
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
257000
CY2023Q4 expi Research And Experimental Costs
ResearchAndExperimentalCosts
14757000
CY2022Q4 expi Research And Experimental Costs
ResearchAndExperimentalCosts
8401000
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
4632000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3826000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
15872000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11871000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
74198000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
68676000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2779000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3467000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
656000
CY2023Q4 expi Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
3000
CY2022Q4 expi Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
519000
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
94000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
55000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
71322000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
63979000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2023 expi Withholding Taxes On Undistributed Earnings Of Foreign Subsidiaries
WithholdingTaxesOnUndistributedEarningsOfForeignSubsidiaries
800000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1309000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
530000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
63000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
199000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
325000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
532000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
580000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
205000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1904000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1309000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
530000
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1904000
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q2 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
25000000
CY2023 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
The Company offers a defined contribution savings plan to provide eligible employees with a retirement benefit that permits eligible employees the opportunity to actively participate in the process of building a personal retirement fund. The Company sponsors the defined contribution savings plan. The Company matches a portion of contributions made by participating employees.
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4763000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4720000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3196000
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-001527-index-headers.html Edgar Link pending
0001558370-24-001527-index.html Edgar Link pending
0001558370-24-001527.txt Edgar Link pending
0001558370-24-001527-xbrl.zip Edgar Link pending
expi-20231231.xsd Edgar Link pending
expi-20231231x10k.htm Edgar Link pending
expi-20231231x10k001.jpg Edgar Link pending
expi-20231231x10k002.jpg Edgar Link pending
expi-20231231x10k003.jpg Edgar Link pending
expi-20231231xex10d16.htm Edgar Link pending
expi-20231231xex10d16001.jpg Edgar Link pending
expi-20231231xex10d17.htm Edgar Link pending
expi-20231231xex10d17g001.jpg Edgar Link pending
expi-20231231xex10d17g002.jpg Edgar Link pending
expi-20231231xex10d17g003.jpg Edgar Link pending
expi-20231231xex10d17g004.jpg Edgar Link pending
expi-20231231xex10d17g005.jpg Edgar Link pending
expi-20231231xex10d17g006.jpg Edgar Link pending
expi-20231231xex10d17g007.jpg Edgar Link pending
expi-20231231xex10d17g008.jpg Edgar Link pending
expi-20231231xex10d17g009.jpg Edgar Link pending
expi-20231231xex10d17g010.jpg Edgar Link pending
expi-20231231xex10d17g011.jpg Edgar Link pending
expi-20231231xex10d17g012.jpg Edgar Link pending
expi-20231231xex10d17g013.jpg Edgar Link pending
expi-20231231xex10d17g014.jpg Edgar Link pending
expi-20231231xex10d17g015.jpg Edgar Link pending
expi-20231231xex10d17g016.jpg Edgar Link pending
expi-20231231xex10d17g017.jpg Edgar Link pending
expi-20231231xex10d17g018.jpg Edgar Link pending
expi-20231231xex10d17g019.jpg Edgar Link pending
expi-20231231xex10d17g020.jpg Edgar Link pending
expi-20231231xex10d17g021.jpg Edgar Link pending
expi-20231231xex10d17g022.jpg Edgar Link pending
expi-20231231xex10d17g023.jpg Edgar Link pending
expi-20231231xex10d17g024.jpg Edgar Link pending
expi-20231231xex10d17g025.jpg Edgar Link pending
expi-20231231xex10d17g026.jpg Edgar Link pending
expi-20231231xex10d17g027.jpg Edgar Link pending
expi-20231231xex10d17g028.jpg Edgar Link pending
expi-20231231xex10d17g029.jpg Edgar Link pending
expi-20231231xex10d17g030.jpg Edgar Link pending
expi-20231231xex10d17g031.jpg Edgar Link pending
expi-20231231xex10d17g032.jpg Edgar Link pending
expi-20231231xex10d17g033.jpg Edgar Link pending
expi-20231231xex10d17g034.jpg Edgar Link pending
expi-20231231xex10d17g035.jpg Edgar Link pending
expi-20231231xex10d17g036.jpg Edgar Link pending
expi-20231231xex10d17g037.jpg Edgar Link pending
expi-20231231xex10d17g038.jpg Edgar Link pending
expi-20231231xex10d17g039.jpg Edgar Link pending
expi-20231231xex10d17g040.jpg Edgar Link pending
expi-20231231xex10d17g041.jpg Edgar Link pending
expi-20231231xex10d17g042.jpg Edgar Link pending
expi-20231231xex10d17g043.jpg Edgar Link pending
expi-20231231xex10d17g044.jpg Edgar Link pending
expi-20231231xex10d17g045.jpg Edgar Link pending
expi-20231231xex10d17g046.jpg Edgar Link pending
expi-20231231xex10d17g047.jpg Edgar Link pending
expi-20231231xex10d17g048.jpg Edgar Link pending
expi-20231231xex10d17g049.jpg Edgar Link pending
expi-20231231xex10d17g050.jpg Edgar Link pending
expi-20231231xex10d17g051.jpg Edgar Link pending
expi-20231231xex10d17g052.jpg Edgar Link pending
expi-20231231xex10d17g053.jpg Edgar Link pending
expi-20231231xex10d17g054.jpg Edgar Link pending
expi-20231231xex10d17g055.jpg Edgar Link pending
expi-20231231xex10d17g056.jpg Edgar Link pending
expi-20231231xex10d17g057.jpg Edgar Link pending
expi-20231231xex10d17g058.jpg Edgar Link pending
expi-20231231xex10d17g059.jpg Edgar Link pending
expi-20231231xex10d17g060.jpg Edgar Link pending
expi-20231231xex10d17g061.jpg Edgar Link pending
expi-20231231xex10d17g062.jpg Edgar Link pending
expi-20231231xex10d17g063.jpg Edgar Link pending
expi-20231231xex10d17g064.jpg Edgar Link pending
expi-20231231xex10d17g065.jpg Edgar Link pending
expi-20231231xex10d17g066.jpg Edgar Link pending
expi-20231231xex10d17g067.jpg Edgar Link pending
expi-20231231xex10d17g068.jpg Edgar Link pending
expi-20231231xex10d17g069.jpg Edgar Link pending
expi-20231231xex10d17g070.jpg Edgar Link pending
expi-20231231xex10d17g071.jpg Edgar Link pending
expi-20231231xex10d17g072.jpg Edgar Link pending
expi-20231231xex10d17g073.jpg Edgar Link pending
expi-20231231xex10d17g074.jpg Edgar Link pending
expi-20231231xex10d17g075.jpg Edgar Link pending
expi-20231231xex10d17g076.jpg Edgar Link pending
expi-20231231xex10d17g077.jpg Edgar Link pending
expi-20231231xex10d17g078.jpg Edgar Link pending
expi-20231231xex10d17g079.jpg Edgar Link pending
expi-20231231xex10d17g080.jpg Edgar Link pending
expi-20231231xex10d17g081.jpg Edgar Link pending
expi-20231231xex10d17g082.jpg Edgar Link pending
expi-20231231xex10d17g083.jpg Edgar Link pending
expi-20231231xex10d17g084.jpg Edgar Link pending
expi-20231231xex10d17g085.jpg Edgar Link pending
expi-20231231xex10d17g086.jpg Edgar Link pending
expi-20231231xex10d17g087.jpg Edgar Link pending
expi-20231231xex10d17g088.jpg Edgar Link pending
expi-20231231xex10d17g089.jpg Edgar Link pending
expi-20231231xex10d18.htm Edgar Link pending
expi-20231231xex10d18001.jpg Edgar Link pending
expi-20231231xex14d1.htm Edgar Link pending
expi-20231231xex14d1g001.jpg Edgar Link pending
expi-20231231xex14d1g002.jpg Edgar Link pending
expi-20231231xex14d1g003.jpg Edgar Link pending
expi-20231231xex14d1g004.jpg Edgar Link pending
expi-20231231xex14d1g005.jpg Edgar Link pending
expi-20231231xex14d1g006.jpg Edgar Link pending
expi-20231231xex14d1g007.jpg Edgar Link pending
expi-20231231xex14d1g008.jpg Edgar Link pending
expi-20231231xex14d1g009.jpg Edgar Link pending
expi-20231231xex21.htm Edgar Link pending
expi-20231231xex23d1.htm Edgar Link pending
expi-20231231xex31d1.htm Edgar Link pending
expi-20231231xex31d2.htm Edgar Link pending
expi-20231231xex32d1.htm Edgar Link pending
expi-20231231xex32d2.htm Edgar Link pending
expi-20231231xex4d1.htm Edgar Link pending
expi-20231231xex97.htm Edgar Link pending
expi-20231231xex97001.jpg Edgar Link pending
expi-20231231xex97003.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
expi-20231231_def.xml Edgar Link unprocessable
expi-20231231_lab.xml Edgar Link unprocessable
expi-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
expi-20231231_cal.xml Edgar Link unprocessable
expi-20231231x10k_htm.xml Edgar Link completed